First draft of the human pangenome reference
A consortium of 119 scientists from 60 institutions published in Nature a pangenome combining assembled genomes from 47 people of diverse ancestries, rather than one person. Google adapted DeepVariant to identify variants and DeepConsensus to correct sequencing errors; a long-read assembler achieved over 99.999% final accuracy. This is a draft: benefits for diagnosis and treatment remain prospective.
Technology: DeepVariant and DeepConsensus
Family DeepConsensus: profile · models page
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: The draft pangenome from 47 assemblies was evaluated for accuracy at structural and base-pair levels, and short-read analysis was compared with GRCh38-based workflows (34% fewer small-variant errors).
- Still unknown: The abstract states no explicit limitations; the blog says this is a draft and benefits for diagnosis and treatment remain prospective.
- AI role: Google adapted DeepVariant to call variants and DeepConsensus to correct sequencing errors in the pangenome assembly.
Evidence sources: https://blog.google/innovation-and-ai/technology/health/first-pangenome-reference-nature-paper-ai/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41586-023-05896-x&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: blog. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 1258 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.